CVE:THCX Hydropothecary (THCX) Stock Price, News & Analysis C$5.30 +0.33 (+6.64%) (As of 06/21/2018) Add Compare Share Share Today's RangeC$5.00▼C$5.3750-Day RangeC$5.30▼C$5.3052-Week RangeC$1.10▼C$5.42Volume5.38 million shsAverage Volume2.35 million shsMarket CapitalizationC$949.11 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Hydropothecary alerts: Email Address Ad Behind the MarketsThe $15 "Insider Secret" That Could Save Your RetirementWhat if I told you there's a $15 stock that a billionaire insider just poured $47 MILLION into? That's right. You can grab shares of this potential retirement-maker for less than you'd pay for lunch.Click here to discover the name and ticker of this "$15 billionaire-backed retirement stock" >>> About Hydropothecary Stock (CVE:THCX)The Hydropothecary Corporation, together with its subsidiaries, produces and distributes medical marijuana products. The company is headquartered in Gatineau, Canada.Read More THCX Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart THCX Stock News HeadlinesApril 16, 2023 | finance.yahoo.comAXS CANNABIS ETF ESTIMATED CASH (^THCX-EU)February 25, 2023 | uk.finance.yahoo.comThe Hydropothecary Corporation (HEXO.TO)September 7, 2024 | Porter & Company (Ad)Why billionaires are wiring money to abandoned towns A new force is brewing in these forgotten towns that could soon turn Appalachia into one of America’s most valuable economic hubs – the beating heart of a new multi-billion-dollar revolution. February 17, 2023 | finance.yahoo.comAXS Cannabis ETF (THCX)August 16, 2022 | prnewswire.comOutlook on the Medical Cannabis Global Market to 2027 - Emergence of Cannabis Legalization Presents Opportunities USA - English - USA - English - PR NewswireAugust 15, 2022 | businesswire.comThe Worldwide Medical Cannabis Industry is Expected to Reach $24.8 Billion by 2027 - ResearchAndMarkets.com - Business WireAugust 3, 2021 | gurufocus.comBedel Financial Consulting, Inc. Buys Innovator S&P 500 Power Buffer ETF - GuruFocus.comAugust 2, 2021 | gurufocus.comOptimum Investment Advisors Bu - GuruFocus.comSeptember 7, 2024 | Porter & Company (Ad)Why billionaires are wiring money to abandoned towns A new force is brewing in these forgotten towns that could soon turn Appalachia into one of America’s most valuable economic hubs – the beating heart of a new multi-billion-dollar revolution. July 30, 2021 | markets.businessinsider.comThe Week In Cannabis: Tilray's Huge Week, Colin Hanks, Allen Iverson, Seth Rogen And More - Markets InsiderJuly 30, 2021 | gurufocus.comBaldwin Brothers Inc Buys Marr - GuruFocus.comSee More Headlines Receive THCX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Hydropothecary and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeCVE SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolCVE:THCX CUSIPN/A CIKN/A Webwww.thehydropothecary.com Phone+1-416-7504949FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares179,077,000Free FloatN/AMarket CapC$949.11 million OptionableNot Optionable BetaN/A 7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free Report Key ExecutivesMr. Sebastien G. St-Louis (Age 34)Co-Founder, Pres, CEO & Director Mr. Adam Miron (Age 34)Co-founder, Chief Brand Officer & Director Mr. Ed Chaplin (Age 48)CFO & Corp. Sec. Mr. James McMillan (Age 50)VP of Bus. Devel. Mr. Arno GrollDirector of OperationsKey CompetitorsBausch Health CompaniesTSE:BHCTilray BrandsTSE:TLRYCronos GroupTSE:CRONCanopy GrowthTSE:WEEDKnight TherapeuticsTSE:GUDView All Competitors THCX Stock Analysis - Frequently Asked Questions How have THCX shares performed this year? Hydropothecary's stock was trading at C$5.30 at the start of the year. Since then, THCX shares have increased by 0.0% and is now trading at C$5.30. View the best growth stocks for 2024 here. How do I buy shares of Hydropothecary? Shares of THCX stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. What other stocks do shareholders of Hydropothecary own? Based on aggregate information from My MarketBeat watchlists, some other companies that Hydropothecary investors own include Aurora Cannabis (ACB), Canopy Growth (WEED), Aphria (APHA), Cronos Group (CRON), CannTrust (CTST) and Funko (FNKO). This page (CVE:THCX) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredMy grim warning about AI stocksToday, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S....Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding The Hydropothecary Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Hydropothecary With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.